Simulations Plus, Inc.

50.37 USD
-0.58 (-1.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Simulations Plus, Inc. stock is up 11.54% since 30 days ago. The next earnings date is Jul 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 26 May’s closed higher than April. In the last 1 Unusual Options Trades, there were 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 Apr 18:51 19 Apr, 2024 35.00 CALL 99 0

About Simulations Plus, Inc.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym; IPFsym; RENAsym; MITOsym.